Swisscanto (CH) Index Equity Fund United Kingdom FA GBP

Reference Data

ISIN CH0461413913
Valor Number 46141391
Bloomberg Global ID
Fund Name Swisscanto (CH) Index Equity Fund United Kingdom FA GBP
Fund Provider Swisscanto Fondsleitung AG Zurich
E-Mail: fonds@swisscanto.ch
Fund Provider Swisscanto Fondsleitung AG
Representative in Switzerland
Distributor(s) Schweizerische Kantonalbanken
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Switzerland
Issuing Condition The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets)
Redemption Condition The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets)
Investment Strategy *** Die Anlagen dieses Teilvermögens erfolgen in Anlehnung an den MSCI® United Kingdom Index, welcher von der MORGAN STANLEY CAPITAL INTERNATIONAL INC. (MSCI) fest-gelegt und berechnet wird und darauf ausgelegt ist, die Performance der Mid- und Large Cap Segmente des Marktes des Vereinigten Königreiches (Grossbritannien und Nordirland) zu messen.
Peculiarities

Fund Prices

Current Price * 117.21 GBP 17.04.2025
Previous Price * 117.09 GBP 16.04.2025
52 Week High * 124.47 GBP 03.03.2025
52 Week Low * 107.89 GBP 18.04.2024
NAV * 117.21 GBP 17.04.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 133,256,266
Unit/Share Assets *** 4,983,803
Trading Information SIX

Performance

YTD Performance +2.68% 31.12.2024
17.04.2025
YTD Performance (in CHF) -1.72% 31.12.2024
17.04.2025
1 month -4.32% 17.03.2025
17.04.2025
3 months -1.29% 17.01.2025
17.04.2025
6 months +0.47% 17.10.2024
17.04.2025
1 year +9.03% 17.04.2024
17.04.2025
2 years +12.77% 17.04.2023
17.04.2025
3 years +21.28% 19.04.2022
17.04.2025
5 years +72.85% 17.04.2020
17.04.2025

Tax Data

Equity Participation Rate in % 97.37
Share of Total Fund Assets in %
Real Estate Rate in % 0.00
ADDI
ADDI Date

Top 10 Holdings ***

AstraZeneca PLC 8.68%
Shell PLC 8.56%
HSBC Holdings PLC 7.77%
Unilever PLC 5.68%
RELX PLC 3.59%
BP PLC 3.51%
Rolls-Royce Holdings PLC 3.18%
British American Tobacco PLC 3.16%
GSK PLC 3.03%
London Stock Exchange Group PLC 2.74%
Last data update 31.03.2025

Cost / Risk

TER 0.20%
TER date 30.09.2024
Performance Fee ***
PTR
Max. Management Fee *** 0.40%
Ongoing Charges *** 0.20%
SRRI ***
SRRI date *** 31.03.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)